NSEAgreements20h ago · 30 Oct 2026, 07:07 pm
Agreements
Dishman Carbogen Amcis Limited · DCAL
✦ AI SummaryPromoter Reclassif.
Dishman Carbogen Amcis Limited has informed the Exchange about a Family Settlement Agreement amongst certain promoter/members of the promoter group, which includes a share purchase agreement for the sale of 59.32% of Adimans LLP's equity shares in the Company.
Analysis Scores
Earnings Impact2/10
Growth Catalyst3/10
Governance Concern6/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment4/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Dishman Carbogen Amcis Limited has informed the Exchange about Agreements
Attachments (1)
📄pdf
Download →
DCAL_30102026190545_IntimationunderRegulation30AFSA30102026.pdf
View document text
30th October, 2026
To, To,
The General Manager The Manager,
Department of Corporate Services Listing Department,
BSE Ltd. National Stock Exchange of India Ltd.
Phiroze Jeejeebhoy Towers, “Exchange Plaza”, C-1, Block G,
Dalal Street, Bandra-Kurla Complex,
Mumbai – 400 001. Bandra (E), Mumbai – 400 051.
Ref.: Scrip Code No. : 540701 (Equity) Ref. : (i) Symbol – DCAL
: 975834, 976560, 977467, 977859, 978062, (ii) Series – EQ
978230 and 978323 (Debt)
Sub: Family Settlement Agreement among certain promoter/members of
promoter group of Dishman Carbogen Amcis Limited (“Company”)
Ref: Disclosure under Regulation 30 and Regulation 30A read with clause 5A of
Para A of Part A of Schedule III to the Securities and Exchange Board of
India (Listing Obligations and Disclosure Requirements) Regulations, 2015
(“Listing Regulations”) read with Securities and Exchange Board of India
Master Circular titled ‘Master circular for compliance with the provisions of
the Securities and Exchange Board of India (Listing Obligations and
Disclosure Requirements) Regulations, 2015 by listed entities’ vide Circular
No.: HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 updated on January
30, 2026.
This is to inform you that today the Company has received a letter dated 29th October,
2026 from Mr. Arpit Janmejay Vyas on behalf of the Vyas family regarding a Family
Settlement Agreement (“FSA”) that has been entered into amongst members of the
Vyas Family (who are promoters/members of promoter group of the Company) on 29th
October, 2026.
The Company is not a party to the FSA. This disclosure is being provided to your good
offices in accordance with the provisions of Regulation 30 and Regulation 30A read
with clause 5A of Para A of Part A of Schedule III to the SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015 (as amended till date) (“SEBI Listing
Regulations”), read with the Securities and Exchange Board of India Master Circular
titled ‘Master circular for compliance with the provisions of the Securities and Exchange
Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 by
listed entities’ vide Master Circular No.: HO/49/14/14(7)2025-CFD-POD2/I/3762/
2026 updated on January 30, 2026, and in the interest of maintaining transparency for
stakeholders.
The details required as per aforesaid SEBI Circular read with the SEBI Listing
Regulations are enclosed.
You are requested to take the same on record.
Thank you,
For, Dishman Carbogen Amcis Limited
Shrima Dave
Company Secretary
Encl.: As above
Disclosure of information pursuant to Regulation 30A of SEBI (Listing Obligations
and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular
HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 January 30, 2026
Sr. Particulars Disclosure
a. If the listed entity is a party to Not applicable.
the agreement:
i. details of the
counterparties
(including name and
relationship with the
listed entity);
b. If listed entity is not a party to
the agreement:
i. name of the party i. Arpit Janmejay Vyas (“Arpit”);
entering into such an ii. Deohooti Janmejay Vyas (“Mrs.
agreement and Vyas”);
relationship with the iii. Aditi Janmejay Vyas (“Aditi”);
listed entity; iv. Mansi Janmejay Vyas (“Mansi”);
Mrs. Vyas, Aditi, and Mansi are hereinafter
collectively referred to as “Family B”.
Arpit and Family B are hereinafter
collectively referred to as the “Family
Members” or “Family”.
Arpit, Mrs. Vyas, Aditi, and Mansi are
promoters / members of the promoter
group of Dishman Carbogen Amcis Limited
(“Company”).
ii. details of the Not applicable.
counterparties to the
agreement (including
name and relationship
with the listed entity);
iii. date of entering into the October 29, 2026 (“Execution Date”)
agreement.
c. Purpose of entering into the The Family Members have agreed upon a
agreement family arrangement and settlement to align
the ownership with management of the
Sr. Particulars Disclosure
Family’s business interests, particularly, in
the Company, as well as to realign their
holdings in certain other entities with a
view inter alia to preserve amity and
goodwill amongst them and future
generations of the family, to maintain peace
and harmony and to avoid escalation of
disputes.
d. Shareholding, if any, in the The Company is not a party to the Family
entity with whom the Settlement Agreement (“FSA”).
agreement is executed;
The shareholding of the Family Members in
the Company as per the latest shareholding
pattern disclosed to BSE Limited and
National Stock Exchange of India Limited as
on September 30, 2026 is set out in
Schedule I.
e. Significant terms of the A summary of the key terms of the FSA,
agreement (in brief); relevant to the Company, is set out below:
(i) The FSA records that under a share
purchase agreement (“SPA”)
executed between Adimans
Technologies LLP (“Adimans LLP”)
and Aamanya AG (of which, Arpit is
the sole shareholder), on October
28, 2026, Adimans LLP has agreed to
sell and transfer, and Aamanya AG
has agreed to purchase and acquire,
9,30,02,442 (nine crores thirty lakhs
two thousand four hundred and
forty-two) equity shares
representing 59.32% (fifty nine
point three two percent) (i.e., the
entire shareholding) of Adimans LLP
in the Company, on agreed terms
and in accordance with applicable
law (“DCAL Share Transaction”).
Sr. Particulars Disclosure
(ii) The DCAL Share Transaction, being
an inter-se transfer amongst the
Promoter and Promoter Group, is in
compliance with the exemption
available under Regulation
10(1)(a)(ii) of the SEBI (Substantial
Acquisition of Shares and
Takeovers) Regulations, 2011
(“SAST Regulations”).
(iii) The disclosure regarding the terms
of the SPA has been made to the
stock exchanges on October 29,
2026, which can be referred to for
further details regarding the DCAL
Share Transaction.
(iv) Subject to, and upon completion of
the DCAL Share Transaction, Mrs.
Vyas shall: (a) resign as partner and
designated partner of Adimans LLP
(“Retirement Date”) on agreed
terms; and (b) resign as a director of
the Company, unless she expressly
communicates in writing her
intention to continue, in which event
the Family Members shall discuss the
same.
(v) Members of Family B who are
presently named as part of the
promoter and promoter group in the
shareholding pattern of the
Company shall seek reclassification
as public shareholders of the
Company on the Retirement Date (or
such other extended date as may be
agreed), in accordance with
Regulation 31A of the Securities and
Exchange Board of India (Listing
Sr. Particulars Disclosure
Obligations and Disclosure
Requirements) Regulations 2015.
(vi) The FSA also provides customary
representations and warranties and
obligations (including conduct of
parties till completion of settlement)
in relation to the shares and interest
being realigned thereunder.
f. Extent and the nature of The FSA records the execution of the SPA in
impact on management or respect of the sale of shares of the Company
control of the listed entity; by Adimans LLP to Aamanya AG. As
explained above, the SPA pertains to an
inter-se transfer of shares amongst the
members of the Promoter and Promoter
Group of the Company, and so is an exempt
transaction, pursuant to Regulation
10(1)(a)(ii) of the SAST Regulations.
The aggregate promoter and promoter
group shareholding in the Company shall
remain unchanged post completion of the
DCAL Share Transaction and the
consummation of the transactions under
the FSA.
There is no impact on the management or
control of the Company.
The realignment is such that the
management and control will continue to
be with the Promoter Group and such
understanding is simply being recorded in
the FSA.
g. Details and quantification of Not applicable as the Company is not a
the restriction or liability party to the FSA and no liability or
imposed upon the listed restriction is imposed on the Company.
entity;
Sr. Particulars Disclosure
h. Whether, the said parties are The Family Members are promoters /
rel
[Showing first 8,000 characters — download PDF for full document]